Literature DB >> 8319701

Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children.

G Saggese1, G Federico, R Battini.   

Abstract

We studied, in vivo, the effects of a calcitriol-containing ointment (3 micrograms of calcitriol per gram of petrolatum) topically applied on skin lesions in children affected by psoriasis vulgaris. Each patient was instructed to apply the ointment, about 1 g once a day at bedtime followed by occlusive dressing with plastic wrap, on one-side lesion (treated) and petrolatum alone on the equivalent controlateral site (placebo) (total weekly dose of calcitriol: approximately 21 micrograms/patient). After 4 weeks of topical treatment all children showed a complete clearing of their skin lesions on the treated side, without appreciable changes on the placebo side. Serum ionised calcium, calcium and calcitriol levels or urinary calcium excretion did not vary significantly throughout the period of therapy. These findings suggest that topical calcitriol may be an effective and safe alternative therapy for psoriasis in children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319701     DOI: 10.1007/bf01955893

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  The cytokine network in psoriasis.

Authors:  B J Nickoloff
Journal:  Arch Dermatol       Date:  1991-06

2.  Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.

Authors:  E L Smith; N C Walworth; M F Holick
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

3.  A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis.

Authors:  E L Smith; S H Pincus; L Donovan; M F Holick
Journal:  J Am Acad Dermatol       Date:  1988-09       Impact factor: 11.527

Review 4.  Psoriasis and its treatment.

Authors:  R H Champion
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

5.  Cyclosporine improves psoriasis in a double-blind study.

Authors:  C N Ellis; D C Gorsulowsky; T A Hamilton; J K Billings; M D Brown; J T Headington; K D Cooper; O Baadsgaard; E A Duell; T M Annesley
Journal:  JAMA       Date:  1986-12-12       Impact factor: 56.272

6.  Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules.

Authors:  G Saggese; G Federico; M Balestri; A Toniolo
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

7.  Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.

Authors:  K Kragballe; B T Gjertsen; D De Hoop; T Karlsmark; P C van de Kerkhof; O Larkö; C Nieboer; J Roed-Petersen; A Strand; G Tikjøb
Journal:  Lancet       Date:  1991-01-26       Impact factor: 79.321

8.  [Local treatments of cutaneous psoriasis].

Authors:  O Enjolras
Journal:  Rev Prat       Date:  1991-10-15

9.  Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.

Authors:  C N Ellis; M S Fradin; J M Messana; M D Brown; M T Siegel; A H Hartley; L L Rocher; S Wheeler; T A Hamilton; T G Parish
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

10.  Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.

Authors:  C E Griffiths; J J Voorhees; B J Nickoloff
Journal:  J Am Acad Dermatol       Date:  1989-04       Impact factor: 11.527

View more
  5 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 2.  [Children and adolescents with psoriasis. What therapy is recommended?].

Authors:  M Sticherling
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

3.  Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?

Authors:  Léa Trémezaygues; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 4.  Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.

Authors:  Emily Osier; Barbara Gomez; Lawrence F Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2015-07

Review 5.  Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic.

Authors:  Morten B Haulrig; Claus Zachariae; Lone Skov
Journal:  Psoriasis (Auckl)       Date:  2021-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.